NEU 1.50% $19.10 neuren pharmaceuticals limited

I think that patient number 862 was for end of quarter. Probably...

  1. 1,388 Posts.
    lightbulb Created with Sketch. 284
    I think that patient number 862 was for end of quarter. Probably an average closer to 800 I’d expect might be better in the calculation.
    That would then be approximately $95,000/patient/quarter and translate to between 1000-1200 patients averaging across the period to hit guidance. Obviously lower in q2 and growing through the year.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.